Aurobindo Pharma has informed that a meeting of the board of directors of the company will be held on May 30, 2013, to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2013.
Further, the board will also consider recommendation of Final Dividend, if any, for the year 2012-13.
The above information is a part of company’s filings submitted to BSE.